Tech Company Financing Transactions

Amphora Medical Funding Round

Longitude Capital Management, Baird Capital and Boston Scientific Corporation joined a $35.5 million Series B funding round for Amphora Medical. The financing was announced on 7/21/2017.

Transaction Overview

Company Name
Announced On
7/21/2017
Transaction Type
Venture Equity
Amount
$35,500,000
Round
Series B
Proceeds Purpose
Amphora will use the proceeds from this financing to fund the U.S. pivotal study for its Selective Bladder Denervation System in women with OAB.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1516 West Lake St. 214
Minneapolis, MN 55408
USA
Email Address
Not Recorded
Overview
Amphora is now undergoing the largest contraceptive clinical trial to date. The clinical trial is testing Amphora's efficacy in preventing pregnancy compared to spermicidal vaginal gel, Conceptrol.
Profile
Amphora Medical LinkedIn Company Profile
Social Media
Amphora Medical Company Twitter Account
Company News
Amphora Medical News
Facebook
Amphora Medical on Facebook
YouTube
Amphora Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Danny Sachs
  Danny Sachs LinkedIn Profile  Danny Sachs Twitter Account  Danny Sachs News  Danny Sachs on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/21/2017: Ada Support venture capital transaction
Next: 7/21/2017: SlideBean venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary